Endothelial Cell News 1.36 December 12, 2016 | |
| |
TOP STORYInvestigators examined the angiomodulatory role of tenascin-C. They found that direct contact of endothelial cells with tenascin-C disrupts actin polymerization, resulting in cytoplasmic retention of the transcriptional coactivator YAP. [Cell Rep] Full Article | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)The spatiotemporal localization and expression of Dll4 are critical for sprouting angiogenesis. However, the related mechanisms are poorly understood. Scientists showed that G-protein-coupled receptor-kinase interacting protein-1 is a robust endogenous inhibitor of Dll4-Notch1 signaling that specifically controls stalk cell fate. [Cell Rep] Full Article | Graphical Abstract Adiporedoxin Suppresses Endothelial Activation via Inhibiting MAPK and NF-κB Signaling Adiporedoxin (Adrx) is a recently discovered redox regulatory protein that is preferentially expressed in adipose tissue and plays a critical role in the regulation of metabolism via its modulation of adipocyte protein secretion. Researchers report that Adrx suppresses endothelial cell activation via inhibiting MAPK and NF-kB signaling pathways. [Sci Rep] Full Article A Novel Bioreactor System for the Assessment of Endothelialization on Deformable Surfaces The authors introduced the design and validation of a novel bioreactor system which enables the long-term conditioning of human endothelial cells interacting with artificial materials under dynamic combinations of flow-generated wall shear stress and wall deformation. [Sci Rep] Full Article Researchers paired a novel dual-chamber, organ-on-chip microfluidic device, the NeuroVascular Unit, with small-volume cytokine detection and mass spectrometry analysis to investigate how the blood-brain barrier responds to two different but overlapping drivers of neuroinflammation, lipopolysaccharide and a cytokine cocktail of IL-1β, TNF-α, and MCP1,2. [J Neuroinflammation] Full Article | Press Release | Video Xanthohumol and 8-prenylnaringenin beer polyphenols modulate angiogenesis, being thus targets for type 2 diabetes (T2DM)-related complications. Scientists examined whether polyphenols consumption affects angiogenic paradox and metabolism in a T2DM mouse model. [Mol Nutr Food Res] Abstract Investigators aimed to determine whether hydrogen sulfide (H2S) inhibits pulmonary arterial endothelial inflammation in rats with monocrotaline-induced pulmonary hypertension and its possible mechanisms. [Lab Invest] Abstract Shock Wave Enhances Angiogenesis through VEGFR2 Activation and Recycling The authors aimed at testing whether shock wave (SW)-induced angiogenesis may be through endothelial vascular endothelial growth factor receptor 2 (VEGFR2) signaling and trafficking. Phosphorylation of VEGFR2-Akt-eNOS axis and production of nitric oxide were determined in human umbilical vein endothelial cells treated with SW. [Mol Med] Full Article Resveratrol Rescues Hyperglycemia-Induced Endothelial Dysfunction via Activation of Akt Scientists aimed to investigate the signaling mechanisms underlying the protecting effects of resveratrol against endothelial dysfunction during hyperglycemia in vitro and in vivo. [Acta Pharmacol Sin] Abstract 3D Co-Culture Model to Analyze the Crosstalk between Endothelial and Smooth Muscle Cells The authors developed and validated a modified three dimensional (3D) sandwich co-culture of endothelial cells and smooth muscle cells employing open µ-Slides with a thin glass bottom allowing direct imaging. [Tissue Eng Part C Methods] Abstract | |
| |
REVIEWSVascular Inter-Regulation of Inflammation: Molecular and Cellular Targets for CNS Therapy The authors present key aspects regarding endothelial cell function and tissue remodeling that are particularly affected or aggravated by inflammation. [J Neurochem] Abstract Visit our reviews page to see a complete list of reviews in the endothelial cell research field. | |
| |
SCIENCE NEWSClinically Meaningful Data for Oral Nintedanib in Mesothelioma Presented Boehringer Ingelheim announced that the LUME-Meso Phase II trial in patients with unresectable malignant pleural mesothelioma met its primary endpoint of progression-free survival (PFS). The data showed nintedanib plus pemetrexed/cisplatin demonstrated a meaningful clinical benefit compared to placebo plus pemetrexed/cisplatin, with a significantly improved PFS. Preliminary overall survival data also favored nintedanib. [Press release from Boehringer Ingelheim Pharmaceuticals, Inc. ( PR Newswire Association LLC.) discussing research presented at 17th International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer, Vienna] Press Release | |
| |
INDUSTRY NEWSNovartis announced initial topline results from two pivotal Phase III clinical studies evaluating the safety and efficacy of pegpleranib in combination with Lucentis® for the treatment of neovascular age-related macular degeneration. [Novartis] Press Release Ophthotech Corporation announced that the pre-specified primary endpoint of mean change in visual acuity at 12 months was not achieved in its two pivotal Phase III clinical trials investigating the superiority of Fovista® anti-PDGF therapy in combination with Lucentis® anti-VEGF therapy compared to Lucentis® monotherapy for the treatment of wet age-related macular degeneration. [Ophthotech Corporation] Press Release | |
| |
POLICY NEWSBrexit by the Numbers: The Fear of Brain Drain British universities fear losing large swathes of their research staff as the country faces up to Brexit, the split with the European Union. More than 31,000 academics at UK universities are non-British EU citizens, and so may lose their rights to live in the United Kingdom after Brexit. [Nature Trend Watch] Editorial Italian Scientists Won’t Miss Departing Prime Minister Matteo Renzi Italian politics is in turmoil after the resignation of Prime Minister Matteo Renzi — but researchers say that they are not particularly sad to see him go. In his almost three years in charge, Renzi promised improvements for universities and science but failed to raise the status of research in the country, according to scientists who complain that he also directly interfered in academic affairs. [Nature News] Editorial
| |
EVENTSNEW The Biology of Regenerative Medicine Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Scientist – Molecular Cell Biology (Medical Research Council) Assistant Professor – Regenerative Medicine (University of Cincinnati) Postdoctoral Position – Endothelial Interactions in Vascular Disease (University of Pittsburgh) Postdoctoral Position – Intersectional Genetics (VIB) Postdoctoral Associate – Neuroscience (University of Pittsburgh) Postdoctoral Fellow – Vascular Cell Signaling (Louisiana State University Health Sciences Center) Senior Scientific Researcher – Molecular Oncology (Genentech) Cell Biologist – Pulmonary Vascular Signaling and Endothelial Cell Biology (University of Maryland) Postdoctoral Positions – Vascular and Immune Modulation in Cancer (VIB) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Endothelial Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home Endothelial Cell News Volume 1.36 | Dec 12 2016